JP2019089796A5 - - Google Patents

Download PDF

Info

Publication number
JP2019089796A5
JP2019089796A5 JP2019009896A JP2019009896A JP2019089796A5 JP 2019089796 A5 JP2019089796 A5 JP 2019089796A5 JP 2019009896 A JP2019009896 A JP 2019009896A JP 2019009896 A JP2019009896 A JP 2019009896A JP 2019089796 A5 JP2019089796 A5 JP 2019089796A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
receptor antagonist
kit
dosage form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019009896A
Other languages
English (en)
Japanese (ja)
Other versions
JP6790140B2 (ja
JP2019089796A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019089796A publication Critical patent/JP2019089796A/ja
Publication of JP2019089796A5 publication Critical patent/JP2019089796A5/ja
Application granted granted Critical
Publication of JP6790140B2 publication Critical patent/JP6790140B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019009896A 2013-03-14 2019-01-24 下痢を治療するための製品及び方法 Active JP6790140B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361782608P 2013-03-14 2013-03-14
US61/782,608 2013-03-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018054088A Division JP6473254B2 (ja) 2013-03-14 2018-03-22 下痢を治療するための製品及び方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020184294A Division JP2021046400A (ja) 2013-03-14 2020-11-04 下痢を治療するための製品及び方法

Publications (3)

Publication Number Publication Date
JP2019089796A JP2019089796A (ja) 2019-06-13
JP2019089796A5 true JP2019089796A5 (https=) 2019-10-24
JP6790140B2 JP6790140B2 (ja) 2020-11-25

Family

ID=50680150

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016502404A Active JP6313417B2 (ja) 2013-03-14 2014-03-14 下痢を治療するための製品及び方法
JP2018054088A Active JP6473254B2 (ja) 2013-03-14 2018-03-22 下痢を治療するための製品及び方法
JP2019009896A Active JP6790140B2 (ja) 2013-03-14 2019-01-24 下痢を治療するための製品及び方法
JP2020184294A Pending JP2021046400A (ja) 2013-03-14 2020-11-04 下痢を治療するための製品及び方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2016502404A Active JP6313417B2 (ja) 2013-03-14 2014-03-14 下痢を治療するための製品及び方法
JP2018054088A Active JP6473254B2 (ja) 2013-03-14 2018-03-22 下痢を治療するための製品及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020184294A Pending JP2021046400A (ja) 2013-03-14 2020-11-04 下痢を治療するための製品及び方法

Country Status (20)

Country Link
US (4) US9717726B2 (https=)
EP (3) EP2968205B1 (https=)
JP (4) JP6313417B2 (https=)
KR (4) KR20180088514A (https=)
CN (2) CN108939076A (https=)
AU (3) AU2014239878B2 (https=)
BR (2) BR122017004716A2 (https=)
CA (1) CA2906005C (https=)
DK (1) DK2968205T3 (https=)
ES (2) ES2655505T3 (https=)
HK (1) HK1247557B (https=)
HU (1) HUE035201T2 (https=)
IL (3) IL273377B2 (https=)
MX (2) MX350814B (https=)
MY (1) MY175326A (https=)
PL (1) PL2968205T3 (https=)
PT (1) PT2968205T (https=)
RU (1) RU2015143475A (https=)
WO (1) WO2014152420A2 (https=)
ZA (1) ZA201708539B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9717726B2 (en) * 2013-03-14 2017-08-01 Maregade Rx, LLC Product and method for treating diarrhea
WO2015073573A1 (en) * 2013-11-14 2015-05-21 Jacobs Michael M Compositions and methods for the prevention and treatment of alcohol-induced hangover syndrome
EP3558296B1 (en) 2016-12-23 2023-06-28 Maregade RX, LLC Low dose product and method for treating diarrhea
IT201900012645A1 (it) * 2019-07-23 2021-01-23 Eros Zanotti Una composizione farmaceutica per l'uso nel trattamento delle chinetosi
CN117293008A (zh) * 2019-08-05 2023-12-26 株式会社日立高新技术 等离子处理装置
US20220408780A1 (en) * 2020-02-11 2022-12-29 The E. Wolfson Medical Center A method effective for treating ulcerative colitis
KR102936883B1 (ko) 2021-08-23 2026-03-11 주식회사 히타치하이테크 플라스마 처리 장치 및 플라스마 처리 방법
EP4408414A4 (en) * 2021-09-22 2025-10-22 Hista Rx Llc COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF INTERSTITIAL CYSTITIS

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204118A (en) 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
US5096894A (en) * 1990-04-03 1992-03-17 Bristol-Myers Squibb Company Rice dextrin oral rehydration solution
AU7255094A (en) 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-antihistamine combinations
US6264984B1 (en) * 1999-12-06 2001-07-24 Bristol-Myers Squibb Company Effervescent histamine H2 antagonist composition
US6656492B2 (en) * 2000-06-30 2003-12-02 Yamanouchi Pharmaceutical Co., Ltd. Quick disintegrating tablet in buccal cavity and manufacturing method thereof
BR0116178A (pt) 2000-11-30 2003-10-14 Bio Balance Corp Cepa bacterial, composição probiótica compreendendo uma cepa bacterial, formulação compreendendo pelo menos uma fração volátil de um extrato de planta, aditivo alimentar, processo de preparação de uma fração volátil de uma planta, processo de preparação de uma formulação terapêutica, processo de crescimento de uma cepa bacterial, processo de manufatura de uma composição probiótica, processo de preparo de uma composição probiótica, processo de preparo de uma composição incluindo microorganismos viáveis, dispensador de microorganismo, método de bio controle de um organismo, método para eliminar uma poluição de óleo, método de recuperação de fumaças org‰nicas, produto alimentar e método de preparo inicial para um processo de fermantação
AU2002356715B2 (en) * 2001-11-23 2008-05-15 Janssen Pharmaceutica N.V. The use of anti-histaminics for acute reduction of elevated intracranial pressure
SE528789C2 (sv) 2004-09-10 2007-02-13 Sandvik Intellectual Property PVD-belagt skär av hårdmetall samt sätt att tillverka detta
US20070077300A1 (en) * 2005-09-30 2007-04-05 Wynn David W Oral compositions containing a salivation inducing agent
US20090312358A1 (en) 2006-03-22 2009-12-17 Trustees Of Boston University Method for management of diarrhea
US8207188B2 (en) 2006-04-07 2012-06-26 Michalis Nicolaou Treatment of diseases modulated by a H4 receptor agonist
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
US20090042972A1 (en) * 2006-05-19 2009-02-12 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
EP2559434A3 (en) 2007-02-12 2013-05-29 Mike Nicolaou Treatment of COPD using a histidine decarboxylase inhibitor sole or combined with an anti-H1 drug or with a leucotriene receptor antagonist
CA2721133C (en) * 2007-04-13 2018-11-06 Somaxon Pharmaceuticals, Inc. Low-dose doxepin formulations and methods of making and using the same
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
ES2686129T3 (es) 2012-11-13 2018-10-16 Codiak Biosciences, Inc. Administración de agentes terapéuticos
US9717726B2 (en) * 2013-03-14 2017-08-01 Maregade Rx, LLC Product and method for treating diarrhea
EP3558296B1 (en) 2016-12-23 2023-06-28 Maregade RX, LLC Low dose product and method for treating diarrhea

Similar Documents

Publication Publication Date Title
JP2019089796A5 (https=)
HRP20160189T1 (hr) Liječenje crohnove bolesti lakvinimodom
JP5386173B2 (ja) 閉経前の性的欲求障害の治療のためのフリバンセリンの使用
JP2009525343A5 (https=)
CN110801452B (zh) 一种含有阿利沙坦酯水解产物或其水解产物盐的药物组合物及其用途
HRP20240564T1 (hr) Novi farmaceutski sastav
JP2006104221A5 (https=)
JP2019503365A5 (https=)
JP2016106150A5 (https=)
RU2015143475A (ru) Продукт и способ лечения диареи
JP2012255026A5 (https=)
FI3782612T3 (fi) Sytidiinianalogien oraalisia formulaatioita ja menetelmiä niiden käyttämiseksi
HRP20131120T1 (hr) Farmaceutski pripravak koji sadrži (1s)-1,5-anhidro-1-[5-(4-etoksibenzil)-2-metoksi-4-metilfenil]-1-tio-d-glucitol i metformin, te njegova uporaba za lijeäśenje dijabetesa
HRP20201316T1 (hr) Novi modulatori receptora sfingozin-fosfata
JP2015514739A5 (https=)
JP2010522137A5 (https=)
HRP20140657T1 (hr) Laminin-1 za primjenu radi pojaäśanja regeneracije mišiä†a nakon ozljede ili za bolje zacjeljivanje rana ako se daje sistemski
EP4442321A3 (en) Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor
JP2012502915A5 (https=)
NZ591408A (en) Paracetamol and Calcium carbonate composition
JP2011516544A5 (https=)
WO2009133470A3 (en) Use of dronedarone alone or in combination for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level
RU2005105302A (ru) Композиция бицифадина
JP2013032308A5 (https=)
JP2006517557A5 (https=)